日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Longitudinal ctDNA Monitoring for Postsurgical Disease Surveillance in Patients with Stage I to IIIB Melanoma

对I期至IIIB期黑色素瘤患者进行术后疾病监测的纵向ctDNA监测

Ansstas, George; Khaddour, Karam; Sudhaman, Sumedha; Lin, Karen; Budde, Griffin L; Poklepovic, Andrew; Doonan, Bently P; Mooradian, Meghan J; Sullivan, Ryan J; Ma, Vincent T; Rosiecki, Jeremy; Liu, Steven; Drengler, Ronald; Flora, Daniel B; Beasley, Georgia M; Rhodin, Kristen E; Hyngstrom, John R; Brunsgaard, Elise K; Ortiz, J Bryce; George, Giby V; Krainock, Michael; Liu, Minetta C; Tan, Alan

Randomized Phase I/II Clinical Trial of a Melanoma Helper Peptide Vaccine with or without Systemic Agonistic Anti-CD27 Antibody (Varlilumab)

随机 I/II 期临床试验,评估黑色素瘤辅助肽疫苗联合或不联合全身性激动性抗 CD27 抗体(Varlilumab)的疗效

Ninmer, Emily K; Petroni, Gina R; Gaughan, Elizabeth; Poklepovic, Andrew S; Kaur, Varinder; Haden, Kathleen; Chianese-Bullock, Kimberly A; Smith, Kelly T; Wright, Paul; Bryant, Jennifer L; Brighton, David; Engel, Jack A; Bullock, Timothy N J; Slingluff, Craig L Jr

Case Report: Adjuvant radiation therapy for cardiac intimal sarcoma with long-term disease control

病例报告:辅助放射治疗对心脏内膜肉瘤的长期疾病控制效果

Rosa, Ariel; Roubil, John G; Singh, Raj; Fallahi, Navid; Poklepovic, Andrew; Weiss, Elisabeth

Phase II (Alliance A091802) Randomized Trial of Avelumab Plus Cetuximab Versus Avelumab Alone in Advanced Cutaneous Squamous Cell Carcinoma

II期(Alliance A091802)随机试验:阿维鲁单抗联合西妥昔单抗与阿维鲁单抗单药治疗晚期皮肤鳞状细胞癌的疗效比较

Zandberg, Dan P; Allred, Jacob B; Rosenberg, Ari J; Kaczmar, John M; Swiecicki, Paul; Julian, Ricklie A; Poklepovic, Andrew S; Bauman, Jessica R; Phan, Minh D; Saba, Nabil F; Rivera, Edgardo; Rowland, Kendrith; Davar, Diwakar; Cordes, Julia; Ho, Alan L; Zhang, Miao; Berg, Stephanie A; Munster, Pamela N; Schwartz, Gary K

Risk Factors for COVID-19-Related Hospitalization and Death in Patients With Cancer: The National Cancer Institute COVID-19 in Cancer Patients Study (NCCAPS)

癌症患者 COVID-19 相关住院和死亡的风险因素:美国国家癌症研究所 COVID-19 癌症患者研究 (NCCAPS)

Rini, Brian I; Best, Ana F; Bowman, Mel D; Mishkin, Grace E; Denicoff, Andrea M; Rubinstein, Larry V; Harris, Lyndsay; Geiger, Ann M; Mark, Nicholas M; Pergam, Steven A; Warner, Jeremy L; Khorana, Alok A; Gnjatic, Sacha; Yen, Tina W F; Liles, Darla K; Bestvina, Christine M; Shah, Neil J; Norrell, Jacqueline T; Hershman, Dawn L; Holter-Chakrabarty, Jennifer L; Poklepovic, Andrew S; Chanock, Stephen J; Sankaran, Hari; Korde, Larissa A

Targeting SUMOylation promotes cBAF complex stabilization and disruption of the SS18::SSX transcriptome in synovial sarcoma.

靶向 SUMO 化可促进 cBAF 复合物的稳定,并破坏滑膜肉瘤中的 SS18::SSX 转录组。

Floros Konstantinos V, Fairchild Carter K Jr, Li Jinxiu, Zhang Kun, Roberts Jane L, Kurupi Richard, Paudel Durga, Xing Yanli, Hu Bin, Kraskauskiene Vita, Hosseini Nayyerehalsadat, Shen Shanwei, Inge Melissa M, Smith-Fry Kyllie, Li Li, Sotiriou Afroditi, Dalton Krista M, Jose Asha, Abdelfadiel Elsamani I, Hill Ronald D, Slaughter Jamie M, Shende Mayuri, Lorenz Madelyn R, Tanaka Noritaka, Kajino Taisuke, Nelson Mary L, Hinojosa Mandy R, Kehinde Victor A, Belvin Benjamin R, Sugiokto Febri G, Lai Zhao, Dimopoulos Alexandros C, Boikos Sosipatros A, Stamatouli Angeliki M, Lewis Janina P, Manjili Masoud H, Ebi Hiromichi, Valerie Kristoffer, Li Renfeng, Poklepovic Andrew, Koblinski Jennifer E, Siggers Trevor, Banito Ana, Dozmorov Mikhail G, Jones Kevin B, Radhakrishnan Senthil K, Faber Anthony C

Understanding the Role of Patient-Reported Outcomes for Decision-Making in Early-Phase Dose-Finding Clinical Trials

了解患者报告结局在早期剂量探索临床试验决策中的作用

Brown, Richard; Wages, Nolan A; Liu, Li; Sutton, Arnethea L; Poklepovic, Andrew S

Phase II study of MEK inhibitor trametinib alone and in combination with AKT inhibitor GSK2141795/uprosertib in patients with metastatic triple negative breast cancer

一项针对转移性三阴性乳腺癌患者的MEK抑制剂曲美替尼单药治疗及联合AKT抑制剂GSK2141795/uprosertib治疗的II期研究

Prasath, Vishnu; Boutrid, Hinda; Wesolowski, Robert; Abdel-Rasoul, Mahmoud; Timmers, Cynthia; Lustberg, Maryam; Layman, Rachel M; Macrae, Erin; Mrozek, Ewa; Shapiro, Charles; Glover, Kristyn; Vater, Mark; Budd, G Thomas; Harris, Lyndsay; Isaacs, Claudine; Dees, Claire; Perou, Charles M; Johnson, Gary L; Poklepovic, Andrew; Chen, Helen; Villalona-Calero, Miguel; Carson, William; Stover, Daniel G; Ramaswamy, Bhuvaneswari

The SCD1 inhibitor aramchol interacts with regorafenib to kill GI tumor cells in vitro and in vivo

SCD1抑制剂阿拉姆醇与瑞戈非尼相互作用,可在体外和体内杀死胃肠道肿瘤细胞。

Booth, Laurence; Booth, Michael R; Roberts, Jane L; Yue, Yang; Kinsey, Emily; Poklepovic, Andrew; Boone, David; Cowhart, L Ashley; Baharaff, Allen; Dent, Paul

SWOG/NCI Phase II Dual Anti-CTLA-4/PD-1 Blockade in Rare Tumors: Nonepithelial Ovarian Cancer

SWOG/NCI II期临床试验:双重抗CTLA-4/PD-1阻断疗法治疗罕见肿瘤:非上皮性卵巢癌

Chae, Young Kwang; Othus, Megan; Patel, Sandip Pravin; Wilkinson, Kelly J; Whitman-Purves, Emily M; Lea, Jayanthi; Schallenkamp, John M; Adra, Nabil; Appleman, Leonard J; Alden, Mitchell; Thomes Pepin, Jessica; Ellerton, John A; Poklepovic, Andrew; Walter, Adam; Rampurwala, Murtuza M; Robinson, William R; Kim, Hye Sung; Chung, Liam Il-Young; McLeod, Christine M; Lopez, Gabby; Chen, Helen X; Sharon, Elad; Streicher, Howard; Ryan, Christopher W; Blanke, Charles D; Kurzrock, Razelle